Talimogene Laherparepvec for the Treatment of Peritoneal Surface Malignancies
NCT03663712
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
28
Enrollment
OTHER
Sponsor class
Conditions
Peritoneal Surface Malignancy
Interventions
BIOLOGICAL:
Talimogene Laherparepvec
Sponsor
Dan Blazer III, M.D.